Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A multiadjuvant polysaccharide-amino acid-lipid (PAL) subunit nanovaccine generates robust systemic and lung-specific mucosal immune responses against SARS-CoV-2 in mice.
Pandey B, Wang Z, Jimenez A, Bhatia E, Jain R, Beach A, Maniar D, Hosten J, O'Farrell L, Vantucci C, Hur D, Noel R, Ringuist R, Smith C, Ochoa MA, Roy K. Pandey B, et al. Among authors: hosten j. bioRxiv [Preprint]. 2023 May 8:2023.05.05.539395. doi: 10.1101/2023.05.05.539395. bioRxiv. 2023. PMID: 37215018 Free PMC article. Preprint.
Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccine.
Atalis A, Keenum MC, Pandey B, Beach A, Pradhan P, Vantucci C, Jain R, Hosten J, Smith C, Kramer L, Jimenez A, Ochoa MA, Frey D, Roy K. Atalis A, et al. Among authors: hosten j. bioRxiv [Preprint]. 2022 Feb 2:2022.01.31.478507. doi: 10.1101/2022.01.31.478507. bioRxiv. 2022. Update in: J Control Release. 2022 Jul;347:476-488. doi: 10.1016/j.jconrel.2022.05.023. PMID: 35132413 Free PMC article. Updated. Preprint.
A Dual-Adjuvanted Parenteral-Intranasal Subunit Nanovaccine generates Robust Systemic and Mucosal Immunity Against SARS-CoV-2 in Mice.
Pandey B, Wang Z, Jimenez A, Bhatia E, Jain R, Beach A, Maniar D, Hosten J, O'Farrell L, Vantucci C, Hur D, Noel R, Rinqguist R, Smith C, Ochoa MA, Roy K. Pandey B, et al. Among authors: hosten j. Adv Sci (Weinh). 2024 Oct 1:e2402792. doi: 10.1002/advs.202402792. Online ahead of print. Adv Sci (Weinh). 2024. PMID: 39352717
TLR7 and RIG-I dual-adjuvant loaded nanoparticles drive broadened and synergistic responses in dendritic cells in vitro and generate unique cellular immune responses in influenza vaccination.
Toy R, Keenum MC, Pradhan P, Phang K, Chen P, Chukwu C, Nguyen LAH, Liu J, Jain S, Kozlowski G, Hosten J, Suthar MS, Roy K. Toy R, et al. Among authors: hosten j. J Control Release. 2021 Feb 10;330:866-877. doi: 10.1016/j.jconrel.2020.10.060. Epub 2020 Nov 5. J Control Release. 2021. PMID: 33160004 Free PMC article.
Tumor-Intrinsic Enhancer of Zeste Homolog 2 Controls Immune Cell Infiltration, Tumor Growth, and Lung Metastasis in a Triple-Negative Breast Cancer Model.
Monterroza L, Parrilla MM, Samaranayake SG, Rivera-Rodriguez DE, Yoon SB, Bommireddy R, Hosten J, Barragan LC, Marcus A, Dobosh BS, Selvaraj P, Tirouvanziam R. Monterroza L, et al. Among authors: hosten j. Int J Mol Sci. 2024 May 15;25(10):5392. doi: 10.3390/ijms25105392. Int J Mol Sci. 2024. PMID: 38791429 Free PMC article.
[Hormonal status and hyperthyroidies (author's transl)].
Belabas M, Croizet M, Hosten JF, Ferret-Bouin P, Manciet G, Roger P, Rivière J. Belabas M, et al. Among authors: hosten jf. Sem Hop. 1979 Jun 8-15;55(21-22):1073-8. Sem Hop. 1979. PMID: 225813 French.